Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 
2018 December 11 | Tags: In The News, Stem Cells

The retina is a light-sensitive layer of the eye that is responsible for visual perception. There are several layers of neurons including the photoreceptor cells that are the rods and cones. Cones are responsible for color vision while rods provide black and white vision. Cone photoreceptors in the eye respond to different light wavelengths and enable vision. Read More

What areTechNotes?

Our bi-weekly TechNotes are an easy way for you to keep in touch with how Enzo Life Sciences is living up to our motto: Scientists Enabling Scientists™. Each TechNote connects recently published research with one or more of the many solutions Enzo provides for scientists across the life sciences, drug development, and clinical research communities.

TechNotes in Social Media

2018 November 27 | Tags: In The News, Neuroscience

In a new report, researchers found that regular exercise improved the learning and locomotor ability of mice. The mice had increased histone acetylation in the hippocampus with a higher expression of the brain-derived neurotrophic factor (BDNF) that contributes to neuroprotection. Read More

Never miss a new TechNote!

Receive our TechNotes as soon as they are published.

TechNotes in Social Media

2018 November 13 | Tags: Immunity, In The News, Neuroscience,

Previous reports have hinted at a connection between the gut and PD. The appendix plays a role in our immune system by regulating the makeup of our gut flora. The appendix can act as a reservoir of misfolded alpha synuclein proteins that are linked to the onset of PD. Read More

2018 October 30 | Tags: Cancer, Immunity, In The News

A recent clinical trial suggests that the use of chemotherapy and immunotherapy to treat patients with triple-negative breast cancer can prolong survival. Triple-negative breast cancer is the most aggressive and lethal form of cancer due to the lack of treatment options. The estimated survival rate is approximately 18 months. We have previously reported on what we know about breast cancer biomarkers and a new potential breast cancer treatment. The Phase III trial involved the combined use of a chemotherapy drug (nab-paclitaxel) and a checkpoint inhibitor (atezolizumab) that prolonged survival rates. Read More

What do you think about TechNotes?

comments powered by Disqus

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,